Cargando…

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Detalles Bibliográficos
Autores principales:	Bychkovsky, Brittany L., Lo, Min-Tzu, Yussuf, Amal, Horton, Carrie, Hemyari, Parichehr, LaDuca, Holly, Garber, Judy E., Scheib, Rochelle, Rana, Huma Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224814/ https://www.ncbi.nlm.nih.gov/pubmed/37178433 http://dx.doi.org/10.1007/s10549-023-06928-w

Ejemplares similares

Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception
por: Bychkovsky, Brittany L., et al.
Publicado: (2023)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen
por: Bychkovsky, Brittany, et al.
Publicado: (2022)

Paired tumor sequencing and germline testing in breast cancer management: An experience of a single academic center
por: Elliott, Elizabeth, et al.
Publicado: (2020)

Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022)

Universal Multi Gene Panel Testing For Individuals With Pheochromocytomas And Paragangliomas
por: Horton, Carolyn, et al.
Publicado: (2021)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Are rare cancer survivors at elevated risk of subsequent new cancers?
por: Finkelstein, Dianne M., et al.
Publicado: (2019)

Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations
por: Horton, Carolyn, et al.
Publicado: (2022)

Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield
por: Horton, Carolyn, et al.
Publicado: (2022)

Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception
por: Garman, Katherine S.
Publicado: (2021)

Prevalence of Germline Pathogenic and Likely Pathogenic Variants in Patients With Second Breast Cancers
por: Yao K, Katharine A, et al.
Publicado: (2020)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies
por: Morganti, Stefania, et al.
Publicado: (2023)

PARP inhibition in breast cancer: progress made and future hopes
por: Tung, Nadine, et al.
Publicado: (2022)

PARP inhibitors in the management of breast cancer: current data and future prospects
por: Livraghi, Luca, et al.
Publicado: (2015)

Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes
por: Pesaran, T., et al.
Publicado: (2016)

BRCA1/2 testing: therapeutic implications for breast cancer management
por: Tung, Nadine M., et al.
Publicado: (2018)

Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Zachariah, Nadia Nocera, et al.
Publicado: (2021)

Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer
por: Karam, Rachid, et al.
Publicado: (2019)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016)

Patient Preferences for Lung Cancer Interception Therapy
por: Janssen, Ellen M., et al.
Publicado: (2023)

A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patients
por: LaDuca, Holly, et al.
Publicado: (2019)

Targeting Epigenetic ‘Readers’ with Natural Compounds for Cancer Interception
por: Damiani, Elisabetta, et al.
Publicado: (2020)

Hereditary diffuse gastric cancer: association with lobular breast cancer
por: Schrader, Kasmintan A., et al.
Publicado: (2007)

The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
por: Hu, Chunling, et al.
Publicado: (2020)

Identifying and assessing women at high risk for breast cancer
por: Garber, JE
Publicado: (2009)

Targeting IL-23 for the interception of obesity-associated colorectal cancer
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Cell-free DNA approaches for cancer early detection and interception
por: Medina, Jamie E, et al.
Publicado: (2023)

Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study
por: King, Claire B., et al.
Publicado: (2023)

Patterns of recurrence and metastasis in BRCA1/BRCA2‐associated breast cancers
por: Song, Yun, et al.
Publicado: (2019)

Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer
por: Esplin, Edward D., et al.
Publicado: (2022)

Current Considerations in Surgical Treatment for Adolescents and Young Women with Breast Cancer
por: Murphy, Brittany L., et al.
Publicado: (2022)

Diagnosing hereditary cancer predisposition in men with prostate cancer
por: Pritzlaff, Mary, et al.
Publicado: (2020)

Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
por: Gallagher, Shannon, et al.
Publicado: (2020)

Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?
por: Bognar, Cinthia Leite Frizzera Borges, et al.
Publicado: (2016)

Breast Cancer Stem Cells
por: Crabtree, Judy S., et al.
Publicado: (2018)

Beam intercepting monitors
por: Jung, R
Publicado: (1989)

Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing
por: Horton, Carolyn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cql6eh261ltrq7nv7rmaub7l67